Capsugel Announces Commercial Availability of Modular Automated Sampling Technology
Modular Automated Sampling Technology (MAST) allows direct aseptic transfer of bioreactor samples to analytical devices, providing rapid and reliable data in bioprocessing.
Capsugel announced that its Modular Automated Sampling Technology (MAST) system is now commercially available. This first-of-its-kind technology directly transfers samples from bioreactors to analytical devices while maintaining process sterility. It allows aseptic collection of accurate, representative samples that generate detailed process information in real-time. MAST was developed by Capsugel to address biopharmaceutical product development and processing challenges.
MAST provides a modular system that is readily scalable and suitable for use throughout the product development process. The system instantaneously provides a wide range of information at the molecular level for media, cells and bioreactor products, allowing for rapid response to maintain optimum bioreactor conditions and maximize yields. Capsugel is also collaborating with several analytical equipment suppliers to integrate process analytical technology (PAT) tools into MAST for bioprocessing.
MAST provides for tailored system design and can be readily expanded with additional sampling modules as required. MASTconnect software allows for configurable, flexible, and user-friendly operation of the MAST system, with special modules for sample scheduling, sample navigation, and analytical data management.
Source: Capsugel
Thermo Fisher Opens Advanced Therapies Collaboration Center in California
April 18th 2025The 6000-square-foot facility will provide cell therapy developers the support they need to transition to CGMP manufacturing, and an expanded footprint of the new center is expected to open in Philadelphia later in 2025.
